Silk Road EBITDA vs. Shares Outstanding

Based on the measurements of profitability obtained from Silk Road's financial statements, Silk Road Medical may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Silk Road's ability to earn profits and add value for shareholders.
For Silk Road profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Silk Road to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Silk Road Medical utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Silk Road's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Silk Road Medical over time as well as its relative position and ranking within its peers.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Please note, there is a significant difference between Silk Road's value and its price as these two are different measures arrived at by different means. Investors typically determine if Silk Road is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Silk Road's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Silk Road Medical Shares Outstanding vs. EBITDA Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Silk Road's current stock value. Our valuation model uses many indicators to compare Silk Road value to that of its competitors to determine the firm's financial worth.
Silk Road Medical is rated below average in ebitda category among its peers. It is rated below average in shares outstanding category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Silk Road by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Silk Shares Outstanding vs. EBITDA

EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Silk Road

EBITDA

 = 

Revenue

-

Basic Expenses

 = 
(55.48 M)
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Silk Road

Shares Outstanding

 = 

Public Shares

-

Repurchased

 = 
40.63 M
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.

Silk Shares Outstanding Comparison

Silk Road is currently under evaluation in shares outstanding category among its peers.

Silk Road Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Silk Road, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Silk Road will eventually generate negative long term returns. The profitability progress is the general direction of Silk Road's change in net profit over the period of time. It can combine multiple indicators of Silk Road, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Silk Road Medical, Inc. operates as a medical device company in the United States. The company was incorporated in 2007 and is headquartered in Sunnyvale, California. Silk Road operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 352 people.

Silk Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Silk Road. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Silk Road position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Silk Road's important profitability drivers and their relationship over time.

Learn to be your own money manager

Our tools can tell you how much better you can do entering a position in Silk Road without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Companies Directory Now

   

Companies Directory

Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
All  Next Launch Module

Use Investing Themes to Complement your Silk Road position

In addition to having Silk Road in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Aggressive Defence Thematic Idea Now

Aggressive Defence
Aggressive Defence Theme
Macroaxis small cap, aggressive-outlook picks designed for investors that are willing to accept higher levels of risk to hedge exposure to above-average market volatility. The Aggressive Defence theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Aggressive Defence Theme or any other thematic opportunities.
View All  Next Launch
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Consideration for investing in Silk Stock

If you are still planning to invest in Silk Road Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Silk Road's history and understand the potential risks before investing.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Global Correlations
Find global opportunities by holding instruments from different markets
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets